Search

Your search keyword '"Gross, S.S."' showing total 29 results
Start Over Author "Gross, S.S."
29 results on '"Gross, S.S."'

1. Bidirectional regulation of osteoclast function by nitric oxide synthase isoforms

Author

Brandi, M.L., Hukkanen, M., Umeda, T., Moradi-Bidhendi, N., Bianchi, S., Gross, S.S., Polak, J.M., and MacIntyre, I.

Subjects
Bones -- Growth, Nitric oxide -- Physiological aspects, Immunocytochemistry -- Analysis, Science and technology
Abstract

Immunocytochemistry and Northern blotting during bidirectional regulation of osteoclasts function by nitric oxide, shows the presence of the constitutive calcium-sensitive nitric oxide synthase (cNOS) isoform in normal rat osteoclasts, and in human preosteoclast cell line. The presence of inducible (I) NOS isoform was also demonstrated. A basal level of transcript was observed in human preosteoclast line. Osteoclasts function may require continuous increases in NO production by cNOS against a basal inhibitory background activity of the iNOS isoform.

Published
1995

18. The preferred source of arginine for high-output nitric oxide synthesis in blood vessels

Author

Xie, L., Hattori, Y., Tume, N., and Gross, S.S.

Abstract

L-arginine is the substrate for nitric oxide (NO) production by each of the 3 NO synthase (NOS) isoforms encoded by the mammalian genome. Despite the pivotal roles of NO in mammalian physiology and pathophysiology, the source of arginine for NO synthesis is not clearly defined. In this context, it is notable that cell types that do not have a complete urea cycle often possess the urea cycle enzymes argininosuccinate synthase and argininosuccinate lyase; together, these enzymes confer the ability to regenerate arginine from the NOS product, L-citrulline. Herein, the authors summarize evidence to support the view that argininosuccinate synthase and argininosuccinate lyase function in an arginine-citrulline cycle, providing a ready source of arginine for high-output NO synthesis. The arginine-citrulline cycle is induced in vascular cells by the same cytokines that trigger iNOS expression and provides the preferred source of substrate for NO production. Evidence suggests that argininosuccinate synthase activity is rate-limiting to high-output NO synthesis and, hence, represents a novel target for the treatment of pathophysiological conditions arising from NO overproduction.

Published
2000
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results